Troponin Levels in Patients in Acute Phase of Stroke |
Author : Edyta Dziadkowiak*, Justyna Chojdak, Maciej Guzinski, Katarzyna Lewczuk, Leszek Noga, Alicja Kostecka and Boguslaw Paradowski |
Abstract | Full Text |
Abstract :Background and Purpose: The purpose of this study was to assess the correlation of cTn levels in the acute phase of ischemic stroke with the extent of stroke, the degree of disability assessed on the modified Rankin Scale, and their prognostic significance. |
|
Valsalva Maneuver in diastolic heart failure, diastolic dysfunction and systolic heart failure clinically BNP and echocardiography |
Author : Hosam I kandil, Mohamed M Abd el ghany, Hussein Risk, Reham M darwish, Dina Osama and Manal A Ibrahim* |
Abstract | Full Text |
Abstract :Background: Valsalva maneuver one of the oldest method to diagnose heart failure, it’s cheap ,non-invasive ,bedside tool .Its well-studied in systolic heart failure patients which showed abnormal response either square wave or absent phase IV ,however in diastolic heart failure and diastolic dysfunction were not investigated . |
|
Cardio-diabetology: New subspecialty and collaborative work to defeat the burden of deadly duo |
Author : Han Naung Tun* |
Abstract | Full Text |
Abstract :Cardiovascular disease (CVD) is one of the most global threatened diseases; particularly coronary artery disease (CAD) is a major deadly attack around the world. Diabetes mellitus (DM) is associated with a 2 to 4-fold increased mortality risk from heart disease. Diabetes related microvascular complication is seemed to be a hazardous factor for cardiovascular system and likely to cause coronary arteries disease, hypertension, peripheral arteries, and carotid vessels, especially seen in the type 2 DM populations. The severity of cardiovascular complications are related to prolong hyperglycemia and the control of dysglycemia. Thus, effective glycemic control is one of the imperative aspects of the management for the prevention of CVD in diabetes. In addition, different kinds of antidiabetes agents have different mechanism of actions that has impacted to cardiovascular outcome. The benefit and risk of current anti-diabetic agents are needed to define clearly and that is needed to promote effective clinical care between cardiology and diabetology. There are multiple complications and sequelae of diabetes that requires the involvement of cardiologic expertise in the diabetes care setting in heart disease population. Therefore, the close cooperation between the cardiologist and the diabetologist is new perceptive way of care to defeat diabetes related cardiovascular complications. |
|
An Updated Systematic Review and Meta-analysis of the Short- and Long-term Outcomes of Percutaneous Coronary Intervention for Patients with Severe Left Ventricular Systolic Dysfunction |
Author : Nuremanguli Abudukeremu§, Zi- Xiang Yu1§, Yi-Ning Yang, Siew- Pang Chan, Xiao-Mei Li, Fen Liu, Yi-Tong Ma* |
Abstract | Full Text |
Abstract :Background: Coronary artery disease (CAD) is the most common cause of left ventricular dysfunction
(LVD). Confl icting evidence exists with regards to available treatments and patient prognosis.
Revascularization may improve ventricular function while coronary artery bypass surgery (CABG) has
signifi cantly improved survival. The effectiveness of percutaneous coronary intervention (PCI) has also
not been thoroughly investigated to date. |
|
Interdisciplinary stepwise approach for an effective and safe Mechanical Transvenous Lead Extraction |
Author : Valentino Borghetti*, Giovanni Carreras, Chiara Marini, Stefano Donzelli, Giancarlo D’Addario, Enrico Boschetti and Alessandro Pardini |
Abstract | Full Text |
Abstract :Aims: Mechanical force applied during leads removal is the main cause for major complications and
cardiovascular injuries. Aim of this study was to retrospectively analyse safety and effectiveness of a
stepwise interdisciplinary approach for mechanical transvenous lead extraction. |
|
Nature of Human Gut Microbiome: How do they play in Cardiovascular Disease? |
Author : Han Naung Tun* |
Abstract | Full Text |
Abstract :
Cardiovascular disease is the number one killer of death around the world. Most of the cardiovascular diseases are caused by sedentary life style, bad eating habit, tobacco smoking, high alcohol intake, dyslipidemia and genetic factors .Recently the idea of human microbiome science has emerged in diseases pathogenesis .The human gut is a house of trillions of microbial floral. Since a couple of decades ago, there has been interesting insights into the human gut microbiota and have highlighted its increasingly association to cardiovascular (CV) and metabolic diseases. Trimethylamine N-oxide (TMAO), which is a metabolic product from gut microbiota plays a central role in cardiovascular disease pathogenesis. Nature of microbial inhabitants within the host has been noticed by the numbers of scientists and researchers to understand more about the hidden mechanism of diseases pathogenesis including cardiovascular disease, metabolic and autoimmune diseases and it has become a good hope to develop new drug designs to prevent metabolic and cardiovascular disease in near future.
|
|
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial |
Author : Mohammed Habib* |
Abstract | Full Text |
Abstract :Background: We compared the angiotensin receptor–neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction.
Methods: In this double-blind trial, we randomly assigned 8442 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive either LCZ696 (at a dose of 200 mg twice daily) or enalapril (at a dose of 10 mg twice daily), in addition to recommended therapy. The primary outcome was a composite of death from cardiovascular causes or hospitalization for heart failure, but the trial was designed to detect a difference in the rates of death from cardiovascular causes. |
|
Disparity between estimates and measures of maximum heart rate in pilots with coronary artery disease |
Author : Jeffrey Dwyer* |
Abstract | Full Text |
Abstract :Background : Several studies indicate that HRmax estimates using the traditional equation, HRmax = 220 - Age, may represent a regression slope and intercept that does reflect the true relationship between age and maximal cardiac frequency. Meta-analysis of several pertinent studies indicates that 220-Age significantly under-estimates the true HRmax, particularly in older patients. This is a critical issue in the exercise evaluation of pilots with CAD who seek reinstatement of an aviation medical certificate after a cardiac illness because end-points in exercise testing and fitness assessment are based upon the 220--Age method of HRmax estimation. |
|
Frequency of Ventricular Arrhythmias in Acute Myocardial Infarction and its relationship with Hypokalemia |
Author : Muzaffar Ali*, Muhammad Umer, Usman Mahmood Butt, Shahzad Tawwab, Mamoon Akbar Qureshi and Zubair Akram |
Abstract | Full Text |
Abstract :Introduction: Arrhythmic complications of acute myocardial infarction like ventricular arrhythmias are common and determine the clinical outcome. The associated risk factors like potassium level may help triage the patients to reduce mortality. |
|